Endophenotyping: a window to the pathophysiology of dystonia.
Meunier
Sabine
S
Hallett
Mark
M
D002540:Cerebral Cortex / Q000378:metabolism / Q000503:physiopathology; D004421:Dystonia / Q000175:diagnosis* / Q000235:genetics* / Q000503:physiopathology; D006580:Genetic Carrier Screening / Q000379:methods*; D005819:Genetic Markers / Q000235:genetics; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005820:Genetic Testing / Q000379:methods* / Q000639:trends; D005838:Genotype; D006579:Heterozygote; D006801:Humans; D008569:Memory Disorders / Q000175:diagnosis / Q000235:genetics; D018832:Molecular Chaperones / Q000235:genetics; D009154:Mutation / Q000235:genetics; D009460:Neurologic Examination / Q000379:methods / Q000639:trends; D010641:Phenotype; D011237:Predictive Value of Tests; D020886:Somatosensory Disorders / Q000150:complications / Q000175:diagnosis / Q000235:genetics
D005819:Genetic Markers; D018832:Molecular Chaperones; C108175:TOR1A protein, human